Imatinib mesylate (Gleevec) for disease relapse following allogeneic bone marrow transplantation.

被引:0
|
作者
Soiffer, RJ [1 ]
Galinsky, I [1 ]
DeAngelo, D [1 ]
Alyea, EP [1 ]
Antin, JH [1 ]
Restas, D [1 ]
Stone, RM [1 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1682
引用
收藏
页码:400A / 400A
页数:1
相关论文
共 50 条
  • [11] Hepatic complications of allogeneic bone marrow transplantation.
    Ustun, C
    Koc, H
    Karayalcin, S
    Akyol, G
    Gurman, G
    Ilhan, O
    Akan, H
    Ozcan, M
    Arslan, O
    Konuk, N
    Uysal, A
    Beksac, M
    BLOOD, 1996, 88 (10) : 3815 - 3815
  • [12] Use of cryopreserved bone marrow in allogeneic transplantation.
    Boccaccio, C
    Beaujean, F
    Kuentz, M
    Rio, B
    Belanger, C
    Buzyn, A
    Sutton, L
    LeBlond, V
    Vernant, JP
    BONE MARROW TRANSPLANTATION, 1998, 21 : S92 - S92
  • [13] Relapse of Graves' disease after successful allogeneic bone marrow transplantation
    Hsiao, LT
    Liu, JH
    Yen, CC
    Wang, WS
    Fan, FS
    Chiou, TJ
    Chen, PM
    BONE MARROW TRANSPLANTATION, 2001, 28 (12) : 1151 - 1153
  • [14] Relapse of Graves' disease after successful allogeneic bone marrow transplantation
    L-T Hsiao
    J-H Liu
    C-C Yen
    W-S Wang
    FS Fan
    T-J Chiou
    P-M Chen
    Bone Marrow Transplantation, 2001, 28 : 1151 - 1153
  • [15] Molecular response to imatinib mesylate following relapse after allogeneic SCT for CML
    McCann, SR
    BLOOD, 2003, 101 (03) : 1200 - 1201
  • [16] Extra-medullary relapse of leukemia following allogeneic bone marrow transplantation
    Au, WY
    Kwong, YL
    Lie, AKW
    Ma, SK
    Liang, R
    HEMATOLOGICAL ONCOLOGY, 1999, 17 (02) : 45 - 52
  • [17] A new model of endogeneous AML following irradiation and allogeneic bone marrow transplantation.
    Van Wijmeersch, B
    Sprangers, B
    De Wolf-Peeters, C
    Landuyt, W
    Waer, M
    Dubois, B
    Billiau, AD
    CLINICAL IMMUNOLOGY, 2005, 115 : S34 - S34
  • [18] Bone density during the first year following allogeneic blood and marrow transplantation.
    Sullivan, KM
    Stern, JM
    Seidel, K
    Flowers, MED
    Siadak, MF
    Fink, J
    Ott, S
    Appelbaum, FR
    Storb, R
    Sherrard, D
    BLOOD, 1998, 92 (10) : 493A - 493A
  • [19] Isolated extramedullary relapse of CML (in the presence of remission in the marrow) following allogeneic stem cell transplantation.
    Momin, FA
    Sangam, S
    Rajasekhariah, A
    Garner, PK
    Akhtar, AJ
    BLOOD, 2000, 96 (11) : 348B - 348B
  • [20] Imatinib mesylate induces durable complete remission of advanced CML persisting after allogeneic bone marrow transplantation
    Vandenberghe, P
    Boeckx, N
    Ronsyn, E
    Decorte, R
    Verhoef, G
    Hagemeijer, A
    LEUKEMIA, 2003, 17 (02) : 458 - 460